+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis

Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis

Neuroscience Letters 409(1): 5-9

Transglutaminase type 2 (TG2) has recently been implicated in crosslinking of mutant huntingtin protein into aggregates. Here we show that TG2 also crosslinks spinocerebellar ataxia-1 (SCA1) gene product ataxin-1. HeLa cell lysates expressing GFP tagged ataxin-1 with 2, 30 or 82 glutamines showed covalent crosslinking of ataxin-1 when incubated with exogenously added TG2. This crosslinking was inhibited by TG2 inhibitor cystamine. SCA1 transgenic mice which overexpress the mutant ataxin-1 in cerebellar Purkinje cells showed elevated nuclear TG2 in the absence of ataxin-1 nuclear aggregates. The addition of purified TG2 to the nuclear extracts or addition of SCA1 nuclear TG2 to GFP-Q82 HeLa cell lysates resulted in the formation of insoluble aggregates. These data indicate that ataxin-1 is a substrate of TG2. Further, in SCA1 TG2 may translocate to the nucleus in response to nuclear accumulation of mutant ataxin-1 at early stages of the disease.

(PDF emailed within 0-6 h: $19.90)

Accession: 012896059

Download citation: RISBibTeXText

PMID: 17045396

DOI: 10.1016/j.neulet.2006.08.003

Related references

SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis. Progress in Neurobiology 99(3): 179-185, 2013

Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1. Neuroscience Letters 420(1): 53-57, 2007

The cerebellar leucine rich acidic nuclear protein interacts with ataxin-1 Further insight into the pathogenesis of SCA1. American Journal of Human Genetics 61(4 SUPPL ): A51, 1997

Tissue transglutaminase crosslinks erythrocyte membrane proteins in sickle cell disease potential role in vasoocclusion. Clinical Research 38(2): 388A, 1990

Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95(1): 41-53, 1998

The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease. Autoimmunity Reviews 3(2): 13-20, 2004

Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease. Faseb Journal 18(7): 932-934, 2004

Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin. Experimental and Therapeutic Medicine 9(4): 1103-1108, 2015

Thrombin upregulates tissue transglutaminase in endothelial cells: a potential role for tissue transglutaminase in stability of atherosclerotic plaque. Arteriosclerosis, Thrombosis, and Vascular Biology 21(10): 1689-1694, 2001

Identification of a self-association region within the SCA1 gene product, ataxin-1. Human Molecular Genetics 6(4): 513-518, 1997

UbcH6 interacts with and ubiquitinates the SCA1 gene product ataxin-1. Biochemical and Biophysical Research Communications 371(2): 256-260, 2008

Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability. Journal of Neurochemistry 72(3): 889-899, 1999

ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 127(7): 1335-1347, 2006